Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 2 , Pages 120-127 , June 2007

Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers

  • Hrushikesh B. Agashe, PhD

      Affiliations

    • Pharmaceutis Research Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour University, Sagar, India
    • Corresponding Author InformationCorresponding author. Hrushikesh B. Agashe, Institute of Nuclear Medicine and Allied Sciences, Brig. S.K. Mazumdar Road, New Delhi 110054, India
  • ,
  • Anil Kumar Babbar, PhD

      Affiliations

    • Institute of Nuclear Medicine and Allied Sciences, New Delhi, India
  • ,
  • Sanyog Jain, PhD

      Affiliations

    • Institute of Nuclear Medicine and Allied Sciences, New Delhi, India
  • ,
  • Rakesh Kumar Sharma, PhD

      Affiliations

    • Institute of Nuclear Medicine and Allied Sciences, New Delhi, India
  • ,
  • Anil Kumar Mishra, PhD

      Affiliations

    • Institute of Nuclear Medicine and Allied Sciences, New Delhi, India
  • ,
  • Abhay Asthana, PhD

      Affiliations

    • Pharmaceutis Research Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour University, Sagar, India
  • ,
  • Minakshi Garg, PhD

      Affiliations

    • Pharmaceutis Research Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour University, Sagar, India
  • ,
  • Tathagata Dutta, PhD

      Affiliations

    • Pharmaceutis Research Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour University, Sagar, India
  • ,
  • Narendra Kumar Jain, PhD

      Affiliations

    • Pharmaceutis Research Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour University, Sagar, India

Received 27 November 2006 ,Accepted 5 February 2007.

References 

  1. Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, et al. A new class of polymers: starburst dendrimeric macromolecules. J. Polym. 1985;17:117–132
  2. de Braber-van den Berg EMM, Meijer EW. Poly(propylene imine) dendrimers: large scale synthesis by heterogeneously catalyzed hydrogenation. Angew Chem Int Ed Engl. 1993;32:1308–1311
  3. Hawker CJ, Wooly KL, Frechet JMJ. Unimolecular micelles and globular amphiphiles: dendrimeric macromolecules as novel recyclable solubilization agents. J Chem Soc Perkin Trans. 1993;1:1287–1297
  4. Liu M, Kono K, Frechet JMJ. Water soluble unimolecular micelles: their potential as drug delivery agents. J Control Rel. 2000;65:121–131
  5. Stevelmans S, van Hest JGM, Jansen JFGA, van Bixtel DAFG, de Brabander-van den Berg EMM, Meijer EW. Synthesis, characterization, and guest host properties of inverted unimolecular dendrimeric micelles. J Am Chem Soc. 1996;118:7398–7399
  6. Newkome GR, He E, Morefield CN. Supramolecules with novel properties: metallodendrimers. Chem Rev. 1999;99:1689–1746
  7. Khandare J, Kolhe P, Pillai O, Kannan S, Leih-Lai M, Kannan RK. Synthesis, cellular transport, and activity of polyamidoamine dendrimers-methyl prednisolone conjugates. Bioconjugate Chem. 2005;16:330–337
  8. Papagiannaross A, Dimas K, Papaioannal GT, Demetzos C. Doxorubicin-PAMAM dendrimers complex attached to liposomes: cytotoxic studies against human cancer cell lines. Int J Pharm. 2005;302:29–38
  9. Kolhe P, Mishra E, Kannan RM, Kannan S, Lieh-Lai M. Drug complexation in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int J Pharm. 2003;259:143–160
  10. Kojima C, Kono K, Maruyama K, Takagishi T. Synthesis of polyamidoamine dendrimers having poly(ethylene) glycol grafts and their ability to encapsulate anticancer drugs. Bioconjugate Chem. 2000;11:910–917
  11. Ambade AV, Savariar E, Thayumanavan S. Dendrimeric micelles for controlled drug release and targeted delivery. Mol Pharm. 2005;2:264–272
  12. Kohle P, Khandare J, Pillai O, Kannan S, Lieh-Lai M, Kannan RM. Preparation, cellular transport and activity of polyamidoamine-based dendrimeric nanodevices with a high drug payload. Biomaterials. 2005;27:660–669
  13. Khandare J, Kolhe P, Pillai O, Kannan S, Lieh-Lai M, Kannan RM. Synthesis, cellular transport and activity of polyamidoamine dendrimer-methylprednisolone conjugates. Bioconjugate Chem. 2005;16:330–337
  14. Aulenta F, Hayes W, Rannard S. Dendrimers: a new class of nanoscopic containers and delivery devices. Eur Polym J. 2003;39:1741–1771
  15. Kihara F, Arima H, Tsutsumi T, Hirayama F, Uekama K. In vitro and in vivo gene transfer by optimized (-cyclodextrin conjugate with polyamido amine dendrimer. Bioconjugate Chem. 2003;14:342–350
  16. Zinselmeyer BH, Mackay SP, Schatzlein AG, Uchegbu IF. The lower-generation polypropyleneimine dendrimers are effective gene transfer agents. Pharm Res. 2002;19:960–967[judy]
  17. Jayaraman N, Nepogodier SA, Stoddart JF. Synthetic carbohydrate containing dendrimers. Chem Eur J. 1997;38:1193–1199
  18. Roy R, Zanini D, Meunier S, Romanowska A. Solid phase synthesis of dendrimeric sialoside inhibitors of influenza A virus hemaglutinin. J Chem Soc Commun. 1993;24:1869–1872
  19. Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, et al. Dendrimers: relationship between structure and biocompatibility in vitro and preliminary studies on the biodistribution of 125I-labeled polyamidoamine dendrimers in vivo. J Control Rel. 2000;65:133–148
  20. Roberts JC, Balghat MK, Zera RT. Preliminary biological evaluations of polyamidoamine (PAMAM) starburst dendrimers. J Biomed Res. 1996;30:53–65
  21. Wilbur DS, Pathare PP, Hamlin DK, Bhular KR, Vessela RL. Biotin reagents for antibody pretargeting, 3. Synthesis, radioiodination, and evaluation of biotinylated starburst dendrimers. Bioconjugate Chem. 1998;9:813–825
  22. Ashton PR, Boyd SE, Brown CL, Nepogodier SA, Meijer EW, Peerlings HWI, et al. Synthesis of glycodendrimers by modification of poly(propylene imine) dendrimers. Chem Eur J. 1997;3:974–984
  23. Reddy LH, Sharma RK, Chuttani K, Mishra AK, Murthy RSR. Influence of administration route on tumour uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumour bearing mice. J Control Rel. 2005;105:185–198
  24. Reddy LH, Sharma RK, Murthy RSR. Enhanced tumour uptake of doxorubicin loaded poly(butyl cynoacrylate) nanoparticles in mice bearing Dalton's lymphoma tumours. J Drug Target. 2004;2:443–451
  25. Thakkar H, Sharma RK, Mishra AK, Chuttani K, Murthy RSR. Efficiency of chitosan microspheres for controlled intra-articular delivery of celecoxib in inflamed joints. J Pharm Pharmcol. 2004;56:1091–1099
  26. Reddy LH, Sharma RK, Chuttani K, Mishra AK, Murthy RSR. Etoposide incorporated tripalmitin nanoparticles with different surface charge: formation, characterization, radiolabeling and biodistribution studies. AAPS J. 2004;6:1–10
  27. Banergee T, Singh AK, Sharma RK, Maitra AN. Labeling efficiency and biodistribution of technetium-99m labeled nanoparticles: influence by colloidal tin particles. Int J Pharm. 2005;289:189–195
  28. Bezouska K. Design, functional evaluation and biomedical application of carbohydrate dendrimers (glycodendrimers). Rev Mol Biotechnol. 2000;90:269–290
  29. Davis BG, Robinson MA. Drug delivery systems based on sugar-macromolecule conjugates. Curr Opin Drug Discovery Dev. 2002;5:279–288
  30. Goyal P, Goyal K, Vijaykumar SG, Singh A, Katare OP, Mishra DN. Liposomal drug delivery systems-clinical applications. Acta Pharm. 2005;55:1–25
  31. Sinha R, Kim GJ, Nie S, Shin DM. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther. 2006;5:1909–1917
  32. Vijayrajkumar P, Asthana A, Dutta T, Jain NK. Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. J Drug Target. 2006;14:546–556
  33. Bhadra D, Yadav AK, Bhadra S, Jain NK. Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. Int J Pharm. 2005;295:221–233
  34. Yamaoka T, Tabata Y, Ikada Y. Distribution and tissue uptake of poly(ethylene) glycol with different molecular weights after intravenous administration to mice. J Pharm Sci. 1994;83:601–606
  35. Drobnik J, Rypeck F. Soluble synthetic polymers in biological systems. Adv Polym Sci. 1984;57:23–49
  36. Roos PH, Hartman HJ, Schlepper-Schofer J, Kolb H, Kolb-Bachofen V. Galactose specific receptors on liver cells II. Characterization of purified receptors from macrophages reveals no structural relationship to hepatocyte receptors. Biochim Biophys Acta. 1985;847:115–121
  37. Jones EA, Summerfield JA. Kupffer cells. In:  Arias IM,  Jakavy WB,  Popper H,  Schacter D,  Shafritz DA editor. The liver: biology and pathobiology. 2nd ed.. New York: Raven; 1988;p. 683–704
  38. Elverold KH, Nedredal GI, Revhaug A, Smedsrd B. Scavenger properties of cultivated pig liver endothelial cell. Comp Hepatol. 2004;3:1–11
  39. Lee YC. Biochemistry of carbohydrate-protein interaction. FASEB J. 1992;6:3193–3200
  40. Ponpipom MM, Bugianesi RL, Robbins JC, Doeberry JC, Shen JY. Cell specific ligands for drug delivery to tissues and organs. J Med Chem. 1981;24:1388–1395
  41. Kichler A, Schuber R. Versatile synthesis of bi- and tri-antenary galactose ligands: interactions with Gal/GalNac receptors of human hepatoma cells. Glycoconj J. 1995;12:275–281
  42. Grandjen C, Rommens C, Gras-Masse H, Melnyk O. One-pot synthesis of antigen bearing, leucine base cluster mannoside using two orthogonal chemoselective ligation interactions. Angew Chem Int Ed. 2000;39:1068–1072
  43. Smith JE, Prison P, Sinden RE. Studies on the kinetics of uptake and distribution of free and liposome entrapped primaquine and of sporozoites by isolated perfused rat liver. Ann Trop Med Parasitol. 1983;77:379–386
  44. Rensen DCN, van Dijk MCM, Havenaar EC, Bijsterbosch MK, Kruijt JK, van Berkel TJC. Selective liver targeting of antiviral by recombinant chylomicrons-a new therapecutic approach to hepatitis B. Nat Med. 1995;1:221–225

 No conflict of interest was reported by the authors of this paper.

PII: S1549-9634(07)00048-2

doi: 10.1016/j.nano.2007.02.002

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 2 , Pages 120-127 , June 2007